Both supporters and opponents of marijuana legalization have both agreed that barriers against cannabis research should be lifted.
Democratic Congressmen Sam Farr (D-Calif.) and Earl Blumenauer (D-Ore.) have teamed up with Republican Congressmen H. Morgan Griffith (R-Va.) and Andy Harris (R-Md.) to introduce the “Credible Research on Medical Efficacy of Marijuana Amendment” to the 21st Century Cures Act, reports the Huffington Post.
The amendment would encourage the National Institutes of Health (NIH) to work with the Drug Enforcement Administration (DEA) in researching the medical risks and benefits of marijuana. It would also reclassify marijuana as a Schedule I subclassification called “Schedule 1R,” which would open up even further access to federal cannabis research.
“As more and more states pass medical marijuana laws, it is clear the federal government needs to rethink our federal policy. Both sides of this issue agree that debate needs to be centered on science and not rhetoric. Allowing research to occur will give policymakers the information necessary to determine the proper role of medical marijuana in our country,” said Congressman Farr in a statement.
Even Rep. Harris, who previously led an unsuccessful effort to block Washington, D.C.’s marijuana legalization program, said that research into the medical efficacy of marijuana is “sorely lacking.”
“Our drug policy should be based on sound science, which is sorely lacking on the medical efficacy of marijuana. We need science to clearly determine whether marijuana has medicinal benefits and if so, what is the best way to gain those benefits. This amendment encourages more research and more collaboration in the study of marijuana by removing barriers currently in place,” said Harris.
Democratic Congressmen Sam Farr (D-Calif.) and Earl Blumenauer (D-Ore.) have teamed up with Republican Congressmen H. Morgan Griffith (R-Va.) and Andy Harris (R-Md.) to introduce the “Credible Research on Medical Efficacy of Marijuana Amendment” to the 21st Century Cures Act, reports the Huffington Post.
The amendment would encourage the National Institutes of Health (NIH) to work with the Drug Enforcement Administration (DEA) in researching the medical risks and benefits of marijuana. It would also reclassify marijuana as a Schedule I subclassification called “Schedule 1R,” which would open up even further access to federal cannabis research.
“As more and more states pass medical marijuana laws, it is clear the federal government needs to rethink our federal policy. Both sides of this issue agree that debate needs to be centered on science and not rhetoric. Allowing research to occur will give policymakers the information necessary to determine the proper role of medical marijuana in our country,” said Congressman Farr in a statement.
Even Rep. Harris, who previously led an unsuccessful effort to block Washington, D.C.’s marijuana legalization program, said that research into the medical efficacy of marijuana is “sorely lacking.”
“Our drug policy should be based on sound science, which is sorely lacking on the medical efficacy of marijuana. We need science to clearly determine whether marijuana has medicinal benefits and if so, what is the best way to gain those benefits. This amendment encourages more research and more collaboration in the study of marijuana by removing barriers currently in place,” said Harris.
No comments:
Post a Comment